Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective study

Table 1 Period prevalence (cases per 100,000 population) of all MRSA cases in Calgary, Canada

Year	Population of Calgary	All MRSA	HA-MRSA	CA-MRSA	CMRSA7 (USA400)	CMRSA10 (USA300)
2004	943,322	22.16	15.27	4.77	1.17	3.60
2005	965,804	46.08	25.16	17.71	1.66	16.05
2006	988812^a	70.69	35.40	30.64	2.12	28.52
2007	1,009,656	90.53	30.41	53.19	2.28	50.91
2008	1,030,940	84.87	26.58	49.28	2.04	47.24
2009	1,052,672	92.53	31.54	51.77	1.42	50.35
2010	1,074,862	86.80	37.96	44.94	3.16	41.77
2011	1096833^a	77.31	29.63	40.94	2.37	38.57
2012	1,123,937	77.05	30.07	40.39	2.49	37.90
2013	1,151,712	77.45	24.40	43.67	3.04	40.64
2014	1,180,172	81.01	26.35	44.32	3.05	41.27

^aPopulation of Calgary was derived from Statistics Canada’s census data for 2006 and 2011 [15, 17]

ISSN: 1471-2458